Stocks News

LAST PRICE
19.0400
TODAY'S CHANGE (%)
Trending Down-1.1600 (-5.7426%)

Bid / Lots
19.0200/ 2
Ask / Lots
19.3000/ 1
Open / Previous Close
20.2300 / 20.2000
Day Range
Low 19.0200
High 20.3400
52 Week Range
Low 3.6000
High 23.6400
Volume
3,624,101
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: ADMA
  
  NEW YORK, NY / ACCESSWIRE / November 16, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Encouraged To Reach Out To The Schall Law Firm, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: ADMA
  
  LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA Biologics" or "the Company") (NASDAQ:ADMA) for violations of the securities laws.
Yesterday
- The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Violating Securities Laws, from 23 hours ago by Dow Jones
  23 hours ago by Dow Jones
  Companies Mentioned: ADMA
  
  LOS ANGELES, CA / ACCESSWIRE / November 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA Biologics" or "the Company") (NASDAQ:ADMA) for violations of the securities laws.
Nov 14, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 6:46PM ET on Thursday Nov 14, 2024 by Dow Jones
  6:46PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: ADMA
  
  NEW YORK, NY / ACCESSWIRE / November 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
- ADMA Biologics, Inc. Is Being Investigated For Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 11:48AM ET on Thursday Nov 14, 2024 by Dow Jones
  11:48AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: ADMA
  
  LOS ANGELES, CA / ACCESSWIRE / November 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA Biologics" or "the Company") (NASDAQ:ADMA) for violations of the securities laws.

Nov 14, 2024
- CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference, from 8:30AM ET on Thursday Nov 14, 2024 by Dow Jones
  8:30AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: CRSP
Nov 13, 2024
- RBC Lifts Price Target on Axsome Therapeutics to $132 From $131, Keeps Outperform Rating, from 7:49AM ET on Wednesday Nov 13, 2024 by MT Newswires
  7:49AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: AXSM
- DJ Axsome Therapeutics Is Maintained at Outperform by Baird, from 7:28AM ET on Wednesday Nov 13, 2024 by Dow Jones
  7:28AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: AXSM
- DJ Axsome Therapeutics Price Target Maintained With a $130.00/Share by Needham, from 5:29AM ET on Wednesday Nov 13, 2024 by Dow Jones
  5:29AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: AXSM
- Arcellx Insider Sold Shares Worth $1,242,170, According to a Recent SEC Filing, from 3:22AM ET on Wednesday Nov 13, 2024 by MT Newswires
  3:22AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: ACLX
Nov 12, 2024
- DJ Arcellx Is Maintained at Buy by Truist Securities, from 12:40PM ET on Tuesday Nov 12, 2024 by Dow Jones
  12:40PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: ACLX
- Top Midday Gainers, from 12:09PM ET on Tuesday Nov 12, 2024 by MT Newswires
  12:09PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: HON, RGEN, AXSM
- Sector Update: Health Care Stocks Mixed Premarket Tuesday, from 9:10AM ET on Tuesday Nov 12, 2024 by MT Newswires
  9:10AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: IBB, RGEN, XLV, AZN, AXSM
- Axsome Therapeutics Q3 Loss Widens, Revenue Increases, from 7:52AM ET on Tuesday Nov 12, 2024 by MT Newswires
  7:52AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: AXSM
- DJ Axsome Therapeutics Price Target Maintained With a $130.00/Share by Needham, from 7:50AM ET on Tuesday Nov 12, 2024 by Dow Jones
  7:50AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: AXSM

ADMA Biologics Inc
NASDAQ:ADMAUnited States

Search Criteria

Today

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 1 hour ago by Dow Jones

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Encouraged To Reach Out To The Schall Law Firm, from 1 hour ago by Dow Jones

Yesterday

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Violating Securities Laws, from 23 hours ago by Dow Jones

Nov 14, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 6:46PM ET on Thursday Nov 14, 2024 by Dow Jones

ADMA Biologics, Inc. Is Being Investigated For Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 11:48AM ET on Thursday Nov 14, 2024 by Dow Jones

Peers Headlines

Nov 14, 2024

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference, from 8:30AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

RBC Lifts Price Target on Axsome Therapeutics to $132 From $131, Keeps Outperform Rating, from 7:49AM ET on Wednesday Nov 13, 2024 by MT Newswires

DJ Axsome Therapeutics Is Maintained at Outperform by Baird, from 7:28AM ET on Wednesday Nov 13, 2024 by Dow Jones

DJ Axsome Therapeutics Price Target Maintained With a $130.00/Share by Needham, from 5:29AM ET on Wednesday Nov 13, 2024 by Dow Jones

Arcellx Insider Sold Shares Worth $1,242,170, According to a Recent SEC Filing, from 3:22AM ET on Wednesday Nov 13, 2024 by MT Newswires

Nov 12, 2024

DJ Arcellx Is Maintained at Buy by Truist Securities, from 12:40PM ET on Tuesday Nov 12, 2024 by Dow Jones

Top Midday Gainers, from 12:09PM ET on Tuesday Nov 12, 2024 by MT Newswires

Sector Update: Health Care Stocks Mixed Premarket Tuesday, from 9:10AM ET on Tuesday Nov 12, 2024 by MT Newswires

Axsome Therapeutics Q3 Loss Widens, Revenue Increases, from 7:52AM ET on Tuesday Nov 12, 2024 by MT Newswires

DJ Axsome Therapeutics Price Target Maintained With a $130.00/Share by Needham, from 7:50AM ET on Tuesday Nov 12, 2024 by Dow Jones